Gao Botao, Associate Chief Physician Primarily engaged in the surgical treatment of pediatric congenital heart disease. Started clinical work in 2002, specializing in the surgical management of congenital heart disease. To date, has performed over 1,500 pediatric cardiothoracic surgeries as the primary surgeon. In 2017, won the championship in the congenital heart disease group at the finals of the 2nd China Young Cardiac Surgeons' Surgical Skills Competition. In 2019, participated in the large-scale Shanghai Medical Experts'巡回 medical mission to Shigatse on behalf of the department and hospital. In the same year, published a SCI paper as the first author with an impact factor of 7.242. **Areas of Expertise:** (I) Minimally invasive treatment of simple congenital heart disease (including atrial septal defect, ventricular septal defect). (II) Various cardiac valve diseases: such as mitral valve, tricuspid valve, aortic valve, and pulmonary valve diseases. (III) Various great vessel diseases: Pulmonary artery diseases such as pulmonary atresia, pulmonary artery hypoplasia, Tetralogy of Fallot; Pulmonary vein diseases such as pulmonary vein stenosis, anomalous pulmonary venous drainage; Aortic diseases such as coarctation of the aorta, aortic arch hypoplasia, supravalvular aortic stenosis, etc. (IV) Others: Such as double outlet right ventricle, atrioventricular septal defect, palliative surgeries (pulmonary artery banding, Glenn, Fontan), mediastinal tumors, pectus excavatum, and other general thoracic diseases. **Main Research Directions:** Surgical treatment of cardiac valve and great vessel diseases; Mechanism study of Kartogenin pretreatment promoting TGF-β3-induced chondrogenic differentiation of bone marrow mesenchymal stem cells and inhibiting ossification.